A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1
Cell Host & Microbe · 2024-09 · 32 (9) · 1536-1551.e6
DOI: 10.1016/j.chom.2024.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2024-09. Verfasst von Gang Luo und 17 weiteren Autor:innen. Beteiligte Einrichtung: Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, Chi…. Hauptthemen laut MEDLINE: Candida albicans, Interferon Regulatory Factor-3, Macrophages, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Candida albicans stably colonizes humans but is the leading cause of hospital-acquired fungemia. Traditionally, masking immunogenic moieties has been viewed as a tactic for immune evasion. Here, we demonstrate that C. albicans blocks type I interferon (IFN-I) signaling via translocating an effector protein Cmi1 into host cells. Mechanistically, Cmi1 binds and inhibits TANK-binding kinase 1 (TBK1) to abrogate IFN-regulatory factor 3 (IRF3) phosphorylation, thereby suppressing the IFN-I cascade. Murine infection with a cmi1 mutant displays an exaggerated IFN-I response in both kidneys and bone-marrow-derived macrophages, leading to rapid fungal clearance and host survival. Remarkably, the lack of CMI1 compromises gut commensalism and increases IFN-I response in mouse colonic cells. These phenotypes of cmi1 are rescued by the depletion of IFN-I receptor. This work establishes the importance of TBK1 inhibition in fungal pathogenesis and reveals that a human commensal-pathogenic fungus significantly impacts host immunity during gut colonization and infection via delivering effector proteins into host cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China.
- College of Life Sciences, Zhejiang University, Hangzhou 310027, China.
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan 430072, China.
- Tianjin Key Laboratory of Function and Application of Biological Macromolecular Structures, School of Life Sciences, Tianjin University, Tianjin 300072, China.
- Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan 430072, China. Electronic address: ylu7@whu.edu.cn.
Förderung
- Natural Science Foundation of Hubei Province
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Information Technology Center, Nagoya University
Zitieren
APA
Luo, G., Zhang, J., Wang, T., Cui, H., Bai, Y., Luo, J., Zhang, J., Zhang, M., Di, L., Yuan, Y., Xiong, K., Yu, X., Zhang, Y., Shen, C., Zhu, C., Wang, Y., Su, C., & Lu, Y. (2024). A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1. Cell Host & Microbe, 32(9), 1536-1551.e6. https://doi.org/10.1016/j.chom.2024.07.003
Vancouver
Luo G, Zhang J, Wang T, Cui H, Bai Y, Luo J, et al. A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1. Cell Host & Microbe. 2024;32(9):1536-1551.e6. doi:10.1016/j.chom.2024.07.003
BibTeX
@article{Luo2024,
author = {Luo, Gang and Zhang, Jingkai and Wang, Tianxu and Cui, Hao and Bai, Yukun and Luo, Jianchen and Zhang, Jinqiu and Zhang, Mao and Di, Linyan and Yuan, Yuncong and Xiong, Kang and Yu, Xiangtai and Zhang, Yaling and Shen, Chao and Zhu, Cheng and Wang, Yong and Su, Chang and Lu, Yang},
title = {A human commensal-pathogenic fungus suppresses host immunity via targeting TBK1},
journal = {Cell Host & Microbe},
year = {2024},
volume = {32},
number = {9},
pages = {1536--1551.e6},
doi = {10.1016/j.chom.2024.07.003}
}
EUVIMED